Candel Therapeutics (CADL) Enterprise Value (2020 - 2025)
Candel Therapeutics recorded quarterly Enterprise Value of -$119.7 million in Q4 2025, down 37.68% quarter-over-quarter from -$87.0 million in Q3 2025, and down 16.64% year-over-year from -$143.6 million in Q4 2024.
Candel Therapeutics' Enterprise Value history runs 6 years deep, the most recent figure standing at -$119.7 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 16.64% year-over-year to -$119.7 million; the TTM figure through Dec 2025 stood at -$119.7 million (down 16.64% YoY), while the FY2025 annual figure was -$119.7 million, down 16.64% from the prior year.
- Enterprise Value came in at -$119.7 million for Q4 2025 at Candel Therapeutics, down from -$87.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$16.6 million in Q3 2024 to a low of -$119.7 million in Q4 2025.
- A 5-year average of -$67.3 million and a median of -$77.2 million in 2022 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 61.48% in 2024 and sank 425.2% in 2025, its largest moves.
- Candel Therapeutics' Enterprise Value stood at -$82.6 million in 2021, then climbed by 15.23% to -$70.1 million in 2022, then surged by 49.45% to -$35.4 million in 2023, then tumbled by 189.88% to -$102.7 million in 2024, then dropped by 16.64% to -$119.7 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$119.7 million, -$87.0 million, and -$100.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Candel Therapeutics | 449.62 Mn | 449.62 Mn | - | -119.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -119.73 Mn |
| Sep 30, 2025 | -86.96 Mn |
| Jun 30, 2025 | -100.69 Mn |
| Mar 31, 2025 | -92.17 Mn |
| Dec 31, 2024 | -102.65 Mn |
| Sep 30, 2024 | -16.56 Mn |
| Jun 30, 2024 | -21.50 Mn |
| Mar 31, 2024 | -25.71 Mn |
| Dec 31, 2023 | -35.41 Mn |
| Sep 30, 2023 | -42.98 Mn |
| Jun 30, 2023 | -51.89 Mn |
| Mar 31, 2023 | -59.26 Mn |
| Dec 31, 2022 | -70.06 Mn |
| Sep 30, 2022 | -77.18 Mn |
| Jun 30, 2022 | -86.78 Mn |
| Mar 31, 2022 | -94.32 Mn |
| Dec 31, 2021 | -82.64 Mn |
| Sep 30, 2021 | -88.39 Mn |
| Jun 30, 2021 | -24.32 Mn |
| Dec 31, 2020 | -35.05 Mn |